Mass General Brigham Cancer Institute is the integrated cancer care and research program of Mass General Brigham, bringing together oncology specialists, researchers, and clinicians from leading Harvard-affiliated hospitals to provide comprehensive cancer treatment, conduct translational and clinical research, and advance innovations in cancer prevention, diagnosis, and therapy.
The organization typically supports legislative policies that promote biomedical research funding, expanded access to cancer screening and treatment, public and private health insurance coverage, clinical trial access, health equity initiatives, and investments in medical innovation and workforce development.
Primary funding sources include patient care revenue, federal and state research grants, philanthropic donations, and institutional support from Mass General Brigham.
Massachusetts General Hospital, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, Harvard Medical School
non-profit academic medical institution
